BioPlus Specialty Pharmacy appoints new SVP
ALTAMONTE SPRINGS, Fla. — BioPlus Specialty Pharmacy has appointed a new SVP to support the company’s growth, the specialty pharmacy provider said.
The company announced the appointment of Elvin Montanez, PharmD, as SVP, saying he would contribute to BioPlus’s development and implementation of growth strategies, noting that he had worked in leadership positions in health care for 20 years.
"I have a passion for bringing value to our customers through pharmaceutical excellence, superior service and innovation," Montanez said. "The demand for cost-effective, quality medical care has never been greater. I am proud to join an organization that shares in this mission to improve the way health care is experienced and delivered."
Par appoints new president, COO
WOODCLIFF LAKE, N.J. — Generic drug maker Par Pharmaceutical has promoted Thomas Haughey to president and Paul Campanelli to COO, the company said. The promotions take effect immediately.
"With the acquisition of Anchen and the pending acquisition of Edict, Par is becoming a larger and more complex organization with three diverse locations and more than 300 additional employees," Par chairman and CEO Patrick LePore said. "These new challenges and opportunities require a president and COO to effectively manage the company and its subsidiaries."
Haughey has served as chief administrative officer since 2008, previously serving as general counsel and secretary, from 2003 to 2006, and as EVP from 2006 to 2008. Campanelli will retain his title of president of Par Pharmaceutical, the company’s generics division, while also assuming responsibility for Strativa Pharmaceuticals, its branded division. Campanelli began working at Par in 2001 as senior director for business development.
BioPlus now offering e-prescribing
ALTAMONTE SPRINGS, Fla. — BioPlus Specialty Pharmacy announced that it now is allowing physicians to electronically submit prescriptions to its pharmacies.
BioPlus said its e-prescribing offering is designed to lessen the risk of errors, lower costs and improve compliance. The use of computerized medication order entry potentially could prevent up to 84% of dose, frequency and route errors in medication use, according to data from the Agency for Healthcare Research and Quality,a Department of Health and Human Services agency.
“Electronic prescriptions were the next step in our Quality Improvement Program, not only ensuring prescription accuracy and security of patient data, but also increasing efficiencies in our clinical departments allowing us to further focus on our key objective – measurably improving patient outcomes,” BioPlus director of technology and operations Eric Jackson said.